Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07886268
PHASE2

A Study to Evaluate the Efficacy and Safety of TP-06 for PCED

Sponsor: Tarsus Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

Capellion is a Phase 2 trial comparing TP-06 2.0% with Vehicle in up to 32 adults with persistent corneal epithelial defects. Participants will receive treatment for 8 weeks and be followed for 2 additional weeks to assess corneal healing and safety.

Official title: A Multicenter, Randomized, Double-Masked, Vehicle Controlled Study to Assess the Efficacy and Safety of TP-06 in Participants With Persistent Corneal Epithelial Defects

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2026-04-20

Completion Date

2028-07-07

Last Updated

2026-10-21

Healthy Volunteers

No

Interventions

DRUG

TP-06

TP-06 ophthalmic solution

DRUG

Vehicle of TP-06

Vehicle of TP-06 ophthalmic solution

Locations (14)

Tarsus Investigative Site

Scottsdale, Arizona, United States

Tarsus Investigative Site

Tampa, Florida, United States

Tarsus Investigative Site

Atlanta, Georgia, United States

Tarsus Investigative Site

Alexandria, Minnesota, United States

Tarsus Investigative Site

Dover, New Jersey, United States

Tarsus Investigative Site

Palisades Park, New Jersey, United States

Tarsus Investigative Site

Babylon, New York, United States

Tarsus Investigative Site

Mt. Pleasant, South Carolina, United States

Tarsus Investigative Site

Houston, Texas, United States

Tarsus Investigative Site

Sugar Land, Texas, United States

Tarsus Investigative Site

Santo Domingo, Dominican Republic

Tarsus Investigative Site

San Salvador, El Salvador

Tarsus Investigative Site

Mexico City, Mexico

Tarsus Investigative Site

Monterrey, Mexico